» Articles » PMID: 36774462

Sarcopenia Index As a Predictor of Clinical Outcomes Among Older Adult Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a Cross-sectional Study

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2023 Feb 11
PMID 36774462
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle mass and function and has a negative impact on clinical outcomes associated with chronic obstructive pulmonary disease (COPD). Recently, the sarcopenia index (SI) was developed as a surrogate marker of sarcopenia based upon the serum creatinine to cystatin C ratio. We aimed to assess the value of SI for predicting clinically important outcomes among elderly patients with acute exacerbation of COPD (AECOPD).

Methods: This cross-sectional study included elderly patients with AECOPD in China from 2017 to 2021. Clinical data were collected from medical records, and serum creatinine and cystatin C were measured. Outcomes included respiratory failure, heart failure, severe pneumonia, invasive mechanical ventilation, and mortality. Binary logistic regression was used to analyze the association between SI and clinical outcomes.

Results: A total of 306 patients (260 men, 46 women, age range 60-88 years) were enrolled in this study. Among the total patients, the incidence of respiratory failure and severe pneumonia was negatively associated with SI values. After adjusting for potential confounding factors, binary logistic regression analyses showed that a higher SI was still independently associated with a lower risk of respiratory failure (odds ratio [OR]: 0.27, 95% confidence interval [CI]: 0.13-0.56, P < 0.05). In subgroup analysis, the incidence of respiratory failure was negatively associated with SI values in groups with both frequent exacerbation and non-frequent exacerbation. After adjustment for potential confounders, binary logistic regression analyses showed that a higher SI was also independently associated with a lower risk of respiratory failure in both groups (OR: 0.19, 95% CI: 0.06-0.64 and OR: 0.31, 95% CI: 0.11-0.85). However, there were no significant differences in the correlations between SI and the risk of heart failure, invasive mechanical ventilation, and mortality in all groups.

Conclusion: The SI based on serum creatinine and cystatin C can predict respiratory failure in patients with AECOPD and either frequent or infrequent exacerbations. This indicator provides a convenient tool for clinicians when managing patients with AECOPD in daily clinical practice.

Citing Articles

Inflammatory markers as predictors of in-hospital mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients with acute respiratory failure: insights from the MIMIC-IV database.

Wang Q, Yang F, Gao L, Xu C, Gao W J Thorac Dis. 2025; 16(12):8250-8261.

PMID: 39831238 PMC: 11740031. DOI: 10.21037/jtd-24-1287.


Sarcopenia Index Is Correlated with Osteoporosis in Patients with Chronic Kidney Disease.

Kim S, Jeong S, Kim K, Sung J, Kim D, Lee S Diagnostics (Basel). 2025; 15(1.

PMID: 39795624 PMC: 11719714. DOI: 10.3390/diagnostics15010096.


The Relationship Between Blood Urea Nitrogen to Creatinine Ratio and Severe Acute Exacerbation of COPD Patients: A Propensity Score Matching Study.

Long Z, Zhu T, Zhou Y, Xiang Z, Zeng Q, Qiu Y Int J Chron Obstruct Pulmon Dis. 2024; 19:2529-2543.

PMID: 39618501 PMC: 11606149. DOI: 10.2147/COPD.S488394.


Relationship between creatinine-cystatin C ratio and all-cause mortality in hospitalized patients with COVID-19: A prospective study in China.

Wu D, Cao J, Lin Y, Chen X, Long B, Huang B Heliyon. 2024; 10(15):e35587.

PMID: 39170472 PMC: 11336739. DOI: 10.1016/j.heliyon.2024.e35587.


Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis.

Zhou J, Liu Y, Yang F, Jing M, Zhong X, Wang Y Int J Chron Obstruct Pulmon Dis. 2024; 19:1613-1622.

PMID: 39011123 PMC: 11246983. DOI: 10.2147/COPD.S456451.


References
1.
Martinez-Llorens J, Orozco-Levi M, Masdeu M, Coronell C, Ramirez-Sarmiento A, Sanjuas C . [Global muscle dysfunction and exacerbation of COPD: a cohort study]. Med Clin (Barc). 2004; 122(14):521-7. DOI: 10.1016/s0025-7753(04)74294-3. View

2.
Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P . Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021; 8(2):1007-1017. PMC: 8006658. DOI: 10.1002/ehf2.13255. View

3.
Kamada T, Ohdaira H, Ito E, Takahashi J, Nakashima K, Nakaseko Y . Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer. Sci Rep. 2022; 12(1):16374. PMC: 9525668. DOI: 10.1038/s41598-022-20967-1. View

4.
Valdiviesso R, Sousa-Santos A, Azevedo L, Moreira E, Amaral T, Silva-Cardoso J . Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study. BMC Cardiovasc Disord. 2022; 22(1):356. PMC: 9354359. DOI: 10.1186/s12872-022-02804-5. View

5.
Fogarty M, Mantilla C, Sieck G . Impact of sarcopenia on diaphragm muscle fatigue. Exp Physiol. 2019; 104(7):1090-1099. PMC: 6602803. DOI: 10.1113/EP087558. View